Trials / Unknown
UnknownNCT03345589
A Trial of 18-22mg/kg/d Ursodeoxycholic in Refractory Primary Biliary Cholangitis
A Randomized Controlled Trial of 18-22mg/kg/d Ursodeoxycholic in Refractory Primary Biliary Cholangitis
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- West China Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates the effect of 18-22mg/kg/d Ursodeoxycholic in refractory Primary Biliary Cholangitis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 18-22mg/kg/d Ursodeoxycholic | 18-22mg/kg/d Ursodeoxycholic |
| DRUG | 13-15mg/kg/d Ursodeoxycholic | 13-15mg/kg/d Ursodeoxycholic |
Timeline
- Start date
- 2018-01-30
- Primary completion
- 2018-12-01
- Completion
- 2019-01-01
- First posted
- 2017-11-17
- Last updated
- 2018-05-03
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03345589. Inclusion in this directory is not an endorsement.